Hamano T - Search Results

1

Fetuin-mineral complex reflects extraosseous calcification stress in CKD.

Hamano T, Matsui I, Mikami S, Tomida K, Fujii N, Imai E, Rakugi H, Isaka Y. Hamano T, et al. J Am Soc Nephrol. 2010 Nov;21(11):1998-2007. doi: 10.1681/ASN.2009090944. Epub 2010 Oct 14. J Am Soc Nephrol. 2010. PMID: 20947626 Free PMC article.

2

Induction of glia maturation factor-beta in proximal tubular cells leads to vulnerability to oxidative injury through the p38 pathway and changes in antioxidant enzyme activities.

Kaimori JY, Takenaka M, Nakajima H, Hamano T, Horio M, Sugaya T, Ito T, Hori M, Okubo K, Imai E. Kaimori JY, et al. Among authors: hamano t. J Biol Chem. 2003 Aug 29;278(35):33519-27. doi: 10.1074/jbc.M301552200. Epub 2003 Jun 5. J Biol Chem. 2003. PMID: 12791701 Free article.

3

Activation of the signal transducer and activator of transcription signaling pathway in renal proximal tubular cells by albumin.

Nakajima H, Takenaka M, Kaimori JY, Hamano T, Iwatani H, Sugaya T, Ito T, Hori M, Imai E. Nakajima H, et al. Among authors: hamano t. J Am Soc Nephrol. 2004 Feb;15(2):276-85. doi: 10.1097/01.asn.0000109672.83594.02. J Am Soc Nephrol. 2004. PMID: 14747374

4

Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.

Hamano T, Oseto S, Fujii N, Ito T, Katayama M, Horio M, Imai E, Hori M. Hamano T, et al. Bone. 2005 May;36(5):909-16. doi: 10.1016/j.bone.2005.02.008. Epub 2005 Mar 24. Bone. 2005. PMID: 15794928

5

Different routes bridging calcium in Japanese hemodialysis patients.

Hamano T, Fujii N, Ito T, Imai E. Hamano T, et al. Ther Apher Dial. 2005 Feb;9(1):32-8. doi: 10.1111/j.1774-9987.2005.00211.x. Ther Apher Dial. 2005. PMID: 15828903

6

[Risedronate: a possible treatment for extraosseous calcification].

Fujii N, Hamano T, Isaka Y, Ito T, Imai E. Fujii N, et al. Among authors: hamano t. Clin Calcium. 2005 Sep;15 Suppl 1:75-8; discussion 78-9. Clin Calcium. 2005. PMID: 16272635 Japanese.

7

[Low dose estrogen replacement therapy (ERT) for postmenopausal hemodialysis (HD) patients].

Hamano T, Fujii N, Ito T, Imai E, Mikami S, Katayama M, Obi Y. Hamano T, et al. Clin Calcium. 2005 Sep;15 Suppl 1:161-6; discussion 166. Clin Calcium. 2005. PMID: 16279020 Clinical Trial. Japanese.

8

Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease.

Hamano T, Fujii N, Nagasawa Y, Isaka Y, Moriyama T, Okada N, Imai E, Horio M, Ito T. Hamano T, et al. Bone. 2006 Nov;39(5):1067-1072. doi: 10.1016/j.bone.2006.04.022. Epub 2006 Jun 16. Bone. 2006. PMID: 16781904

9

Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD).

Fujii N, Hamano T, Mikami S, Nagasawa Y, Isaka Y, Moriyama T, Horio M, Imai E, Hori M, Ito T. Fujii N, et al. Among authors: hamano t. Nephrol Dial Transplant. 2007 Jun;22(6):1601-7. doi: 10.1093/ndt/gfl567. Epub 2006 Nov 23. Nephrol Dial Transplant. 2007. PMID: 17124283 Clinical Trial.

10

[Vitamin D deficiency in CKD patients].

Hamano T. Hamano T. Clin Calcium. 2007 May;17(5):718-24. Clin Calcium. 2007. PMID: 17471001 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

712 results

Search Page

Filters